ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,105Medicare Part D Prescriptions Filled, Including Refills

Rank: 64 out of 1206

$547K Total Retail Price of All Prescriptions

Rank: 126 out of 1206

498 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 498 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

14% of this provider’s 498 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 11,823 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $46 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
SIMVASTATIN 759 675 1 1
LEVOTHYROXINE SODIUM 541 436 2 2
ATORVASTATIN CALCIUM 486 459 3 13
OMEPRAZOLE 434 390 4 3
AMLODIPINE BESYLATE 421 380 5 6
FUROSEMIDE 404 327 6 5
METFORMIN HCL 389 340 7 10
METOPROLOL TARTRATE 350 297 8 9
HYDROCODONE-ACETAMINOPHEN 335 229 S3 9 7
WARFARIN SODIUM 322 303 10 8
METOPROLOL SUCCINATE 306 305 11 15
HYDROCHLOROTHIAZIDE 305 277 12 11
LISINOPRIL 267 228 13 4
ENALAPRIL MALEATE 247 218 14 45
TRAMADOL HCL 236 169 15 17
LOSARTAN POTASSIUM 230 220 16 20
POTASSIUM CHLORIDE 230 219 16 12
ALENDRONATE SODIUM 229 211 18 19
SERTRALINE HCL 224 196 19 22
DIGOXIN 160 160 20 43
ZETIA 154 120 21 73
ZOLPIDEM TARTRATE 141 94 22 25
MELOXICAM 140 131 23 35
LOSARTAN-HYDROCHLOROTHIAZIDE 138 116 24 60
CITALOPRAM HBR 125 96 25 16
GLIMEPIRIDE 124 124 26 34
CRESTOR 123 101 27 30
ALLOPURINOL 123 112 27 24
BENAZEPRIL HCL 122 106 29 39
AZITHROMYCIN 113 99 30 46
TAMSULOSIN HCL 106 104 31 26
ATENOLOL 105 92 32 14
TRIAMTERENE-HCTZ 93 74 33 33
GEMFIBROZIL 89 81 34 71
CLOPIDOGREL 88 72 35 48
DILTIAZEM 24HR CD 87 87 36 67
PREDNISONE 81 77 37 28
CARVEDILOL 81 75 37 32
CYMBALTA 74 24 39 63
EVISTA 73 72 40 129
NAMENDA 72 72 41 36
GABAPENTIN 72 39 41 18
AMITRIPTYLINE HCL 71 60 R 43 59
OXYBUTYNIN CHLORIDE 70 66 44 68
CIPROFLOXACIN HCL 67 54 45 61
KLOR-CON 10 66 63 46 93
FENTANYL 64 43 S2 47 51
DIOVAN 61 46 48 57
NEXIUM 58 24 49 47
TRILIPIX 57 45 50 280
RAMIPRIL 57 57 50 96
LISINOPRIL-HYDROCHLOROTHIAZIDE 56 56 52 27
METHYLPREDNISOLONE 55 46 53 197
GLIPIZIDE 54 43 54 64
BUPROPION HCL SR 54 37 54 171
INSULIN SYRINGE 53 38 56 111
NOVOLIN N 52 48 57 239
PRAVASTATIN SODIUM 51 40 58 21
ISOSORBIDE MONONITRATE ER 50 39 59 40
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 15, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.